UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation

Multiple sclerosis, 2021-05, Vol.27 (6), p.903-912

2021

Volltextzugriff (PDF)

Expanding spectrum of opportunistic infections associated with dimethyl fumarate

Multiple sclerosis, 2021-07, Vol.27 (8), p.1301-1305

2021

Volltextzugriff (PDF)

Reporting Adverse Events for Cannabis to the FDA

The New England journal of medicine, 2020-01, Vol.382 (1), p.98-98

2020

Volltextzugriff (PDF)

Immune-mediated colitis associated with ocrelizumab: A new safety risk

Multiple sclerosis, 2023-09, Vol.29 (10), p.1275-1281

2023

Volltextzugriff (PDF)

Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine

Neurology, 2019-05, Vol.92 (21), p.e2401

2019

Volltextzugriff (PDF)

Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab

Neurology, 2018-05, Vol.90 (18), p.e1548

2018

Volltextzugriff (PDF)

An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System

Drug safety, 2020-05, Vol.43 (5), p.457-465

2020

Volltextzugriff (PDF)

Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility

Drug safety, 2020-04, Vol.43 (4), p.329-338

2020

Volltextzugriff (PDF)

Liver injury associated with dimethyl fumarate in multiple sclerosis patients

Multiple sclerosis, 2017-12, Vol.23 (14), p.1947-1949

2017

Volltextzugriff (PDF)

Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration

Pharmacotherapy, 2019-11, Vol.39 (11), p.1042-1052

2019

Volltextzugriff (PDF)

Response to: Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy in association with zolpidem

European journal of gastroenterology & hepatology, 2017-09, Vol.29 (9), p.1102-1103

2017

Volltextzugriff (PDF)

Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports

Pharmaceutical medicine, 2021-09, Vol.35 (5), p.307-316

2021

Volltextzugriff (PDF)

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance

Drugs -- real world outcomes, 2018-06, Vol.5 (2), p.91-99

2018

Volltextzugriff (PDF)

Drug-risk communication to pharmacists: Assessing the impact of risk-minimization strategies on the practice of pharmacy

Journal of the American Pharmacists Association, 2008-07, Vol.48 (4), p.494-500

2008

Volltextzugriff (PDF)

Mitoxantrone treatment of multiple sclerosis: safety considerations

Neurology, 2005-12, Vol.65 (12), p.1997; author reply 1997

2005

Volltextzugriff (PDF)

Evaluation of a natural language processing tool for extracting gender, weight, ethnicity, and race in the US food and drug administration adverse event reporting system

Frontiers in Drug Safety and Regulation, 2022-11, Vol.2

2022

Volltextzugriff (PDF)

Lamotrigine and aseptic meningitis

Neurology, 2012-03, Vol.78 (12), p.921-927

2012

Volltextzugriff (PDF)

Renal failure associated with the use of celecoxib and rofecoxib

Drug safety, 2002, Vol.25 (7), p.537-544

2002

Volltextzugriff (PDF)

Labeling and Drug Safety Communication Approaches to Loperamide Abuse

JACC. Clinical electrophysiology, 2017-04, Vol.3 (4), p.422-422

2017

Volltextzugriff (PDF)

Seizure Activity and Off-Label Use of Tiagabine

The New England journal of medicine, 2006-02, Vol.354 (7), p.773-774

2006

Volltextzugriff (PDF)

Clinical Profile of Oxcarbazepine-Related Angioneurotic Edema: Case Report and Review

Pediatric neurology, 2007-08, Vol.37 (2), p.134-137

2007

Volltextzugriff (PDF)

Clozapine and Venous Thromboembolism

The American journal of psychiatry, 2002-05, Vol.159 (5), p.876-877

2002

Volltextzugriff (PDF)

Antipsychotic drugs and venous thromboembolism

The Lancet (British edition), 2000-07, Vol.356 (9225), p.252-253

2000

Volltextzugriff (PDF)

Possible short-term memory loss associated with nafarelin acetate

The Annals of pharmacotherapy, 1992-02, Vol.26 (2), p.169-171

1992

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(14)
Clinical Neurology
(9)
Neurosciences & Neurology
(9)
Pharmacology & Pharmacy
(7)
United States
(7)
Adult
(6)
Adverse Drug Reaction Reporting Systems
(5)
Female
(5)
Pharmacovigilance
(5)
Anticonvulsants - Adverse Effects
(4)
Male
(4)
Multiple Sclerosis
(4)
Neurosciences
(4)
Original Research Article
(4)
Pharmacology/toxicology
(4)
United States Food And Drug Administration
(4)
Adolescent
(3)
Algorithms
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation

Expanding spectrum of opportunistic infections associated with dimethyl fumarate

Reporting Adverse Events for Cannabis to the FDA

Immune-mediated colitis associated with ocrelizumab: A new safety risk

Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine

Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab

An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System

Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility

Liver injury associated with dimethyl fumarate in multiple sclerosis patients

Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration

Response to: Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy in association with zolpidem

Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance

Drug-risk communication to pharmacists: Assessing the impact of risk-minimization strategies on the practice of pharmacy

Mitoxantrone treatment of multiple sclerosis: safety considerations

Evaluation of a natural language processing tool for extracting gender, weight, ethnicity, and race in the US food and drug administration adverse event reporting system

Lamotrigine and aseptic meningitis

Renal failure associated with the use of celecoxib and rofecoxib

Labeling and Drug Safety Communication Approaches to Loperamide Abuse

Seizure Activity and Off-Label Use of Tiagabine

Clinical Profile of Oxcarbazepine-Related Angioneurotic Edema: Case Report and Review

Clozapine and Venous Thromboembolism

Antipsychotic drugs and venous thromboembolism

Possible short-term memory loss associated with nafarelin acetate

Suchergebnisse filtern